Ligand Pharmaceuticals | LGND - Ebitda





Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 3.86B 1.28B 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Baxter International USD 309M 756M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Enviri Corporation USD 70.13M 4.29M 2025-12
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD -1.54B 7.84B 2026-03
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 43.96M 1.16M 2026-06